论文部分内容阅读
目的探讨对婴幼儿毛细支气管炎治疗的策略,并制定合理的临床路径。方法选择住院治疗的毛细支气管患儿360例作为研究对象,随机分为观察组和对照组各180例,观察组给予临床路径治疗,对照组给予常规治疗。记录两组患儿治愈率、住院时间、治疗费用、患儿及家属的满意度。结果观察组患儿治愈率为96.67%显著高于对照组的86.11%,差异有统计学意义(P<0.05);观察组患儿住院时间及治疗费用显著低于对照组,患儿及家属对治疗及服务满意度明显高于对照组,差异均有统计学意义(P<0.05)。结论毛细支气管炎患儿进行临床路径治疗能有效改善治疗的效果,减少患儿的住院时间及治疗费用,提高了患儿及家属的满意度。
Objective To explore the strategy of treating bronchiolitis in infants and young children, and to develop a reasonable clinical path. Methods A total of 360 children with bronchial bronchialisation were enrolled in this study. They were randomly divided into observation group (180 cases) and control group (180 cases). The observation group was treated by clinical pathology while the control group was treated by conventional therapy. Record two groups of children cure rate, hospital stay, treatment costs, satisfaction of children and their families. Results The cure rate of observation group was 96.67%, which was significantly higher than that of control group (86.11%), the difference was statistically significant (P <0.05). The hospitalization time and treatment cost in observation group were significantly lower than those in control group, children and relatives Treatment and service satisfaction was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion The clinical pathological treatment of children with bronchiolitis can effectively improve the treatment effect, reduce hospitalization time and treatment costs, and improve the satisfaction of children and their families.